• Verapamil HCl: Calcium Signaling or Drug Efflux?

  2026-08-28

  Verapamil HCl is an L-type calcium channel blocker with applications in apoptosis, myeloma, inflammation, and transporter biology. This article explains how to distinguish calcium-channel effects from P-glycoprotein-mediated drug-efflux modulation when designing rigorous assays.

• Azithromycin Assay Design for Reliable Results

  2026-08-28

  Learn how Azithromycin (SKU B1398) can be incorporated into bacterial infection, resistance, and cell-based assay workflows without confusing antimicrobial activity with host-cell toxicity. This scenario-driven guide covers solvent control, protocol design, MIC interpretation, and practical supplier selection.

• TH287: A Time-Resolved MTH1 Inhibitor Guide

  2026-08-27

  TH287 is a potent MTH1 inhibitor for studying oxidized nucleotide stress and cancer cell vulnerability. This guide explains how treatment sequence, orthogonal readouts, and assay controls improve interpretation of TH287-mediated radiosensitization in CRPC models.

• FPR2/ALX in Autoimmune Astrocytopathy

  2026-08-27

  A 2026 study identifies FPR2/ALX stimulation by Quin-C1 as a way to limit AQP4-IgG- and complement-driven astrocytopathy in mice. The findings connect protection to coordinated modulation of microglia and natural killer cells, with evidence implicating SYK-AKT signaling and offering a mechanistic framework for future neuroimmunology studies.

• CAY10499 for Lipid-Driven Macrophage Assays

  2026-08-26

  CAY10499, an inhibitor of human hormone sensitive lipase, enables causal separation of fatty-acid mobilization, MGL activity, and ACLY-driven macrophage reprogramming. This article presents an assay strategy for interpreting lipid-dependent tumor–immune biology without conflating upstream EV cargo transfer with downstream lipase signaling.

• TH287 Radiosensitizes Castration-Resistant Prostate Cancer

  2026-08-26

  The reference study shows that the MTH1 inhibitor TH287 can increase the response of PC-3 and DU-145 castration-resistant prostate cancer cells to ionizing radiation. Its main practical contribution is the identification of a stronger combination effect when radiation is delivered 12 hours after TH287 exposure, alongside increased apoptosis and cell-cycle disruption.

• Benzyl-activated Streptavidin Magnetic Beads

  2026-08-25

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, peptides, antibodies, nucleic acids, sugars, and other targets from complex samples. They are appropriate for purification, immunoprecipitation, interaction assays, and screening workflows, but require validation for analyte-specific recovery, elution, nonspecific binding, and live-cell compatibility.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-08-25

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) is intended for HRP-based immunoblotting when weak or low-abundance protein bands require a longer imaging window. It is suitable for detection on nitrocellulose and PVDF membranes, but the supplied information does not support extrapolation to diagnostic testing or non-immunoblot assays.

• Bestatin and Actinonin: Intracellular Antiproliferation

  2026-08-24

  The reference study shows that bestatin and actinonin suppress proliferation in U937 and K562 cells mainly through intracellular activity rather than inhibition of cell-surface aminopeptidases. Efflux-modifier experiments further indicate that MRP and, in a cell-dependent manner, P-glycoprotein regulate intracellular drug exposure, providing a mechanistic framework for interpreting transporter effects in hematologic cancer models.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-24

  This study identifies the WNT5a/GSK3/β-catenin axis as a regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By combining pharmacological screening, mass cytometry, animal models, and transcriptomic network analysis, the authors connect impaired WNT5a signaling with fatty degeneration and show that GSK3 inhibition can suppress FAP adipogenesis while improving support for muscle regeneration.

• Stable Yeast Expression of Exendin-4 for Type 2 Diabetes

  2026-08-23

  A 2024 Frontiers in Systems Biology study developed recombinant expression models for Exendin-4 in Escherichia coli and Saccharomyces cerevisiae, with chromosomally integrated yeast producing immunoassay-detectable protein at the expected size. The work is an early synthetic-biology feasibility study: it supports a potentially local and lower-cost production strategy, but does not yet establish peptide yield, receptor activity, oral delivery, or therapeutic efficacy.

• Autophagy, Periostin, and Cementoblast Mineralization

  2026-08-22

  The reference study identifies autophagy as a functional mediator of cementoblast mineralization under compressive force, rather than merely a stress-associated cell process. Its data connect periostin to Wnt transcriptional activity through β-catenin ubiquitination, providing a mechanistic framework for understanding cementum repair and orthodontic root resorption.

• TH287 MTH1 Inhibitor: An Assay Design Guide

  2026-08-21

  Explore how TH287, a potent MTH1 inhibitor, converts oxidized nucleotide stress into measurable cancer-cell death. This assay-centered guide explains radiation timing, orthogonal readouts, controls, and the practical significance of recent CRPC findings.

• AICAR Workflows for AMPK Metabolic Research

  2026-08-20

  AICAR provides a practical pharmacological benchmark for AMPK activation in energy metabolism, inflammation, and hepatic stellate cell assays. This workflow connects the compound to a recent MAFLD fibrosis study while emphasizing dose selection, lipid-droplet readouts, and troubleshooting limits.

• TH287 MTH1 Inhibitor for Cancer Radiosensitization

  2026-08-20

  TH287 converts oxidized nucleotide stress into a measurable cancer-cell vulnerability and provides a practical way to test radiosensitization in CRPC models. This workflow emphasizes treatment sequence, orthogonal DNA-damage readouts, and troubleshooting beyond a single viability endpoint.

8633 records 1/576 page Next 12345 下5页 Last page